HSP90AA1 and colorectal carcinoma: In contrast, the use of Tamox alone in CRC cells significantly increased the HSP90 and TXNDC9 protein levels, while cotreatment with ICA and Tamox led to a slight decrease in the HSP90 and TXNDC9 expression levels compared to those in the group treated with Tamox alone.